Health
Psychedelic drug popular in 1960s could ease anxiety as doctors share warnings
NEWYou can now listen to Fox News articles!
A new study suggests that lysergic acid diethylamide (LSD), also known as acid, could reduce anxiety.
This marks the first-ever trial to evaluate the safety and efficacy of MM120 (a pharmaceutical formulation of LSD) as a monotherapy for patients with moderate to severe generalized anxiety disorder, according to lead author Daniel Karlin, M.D., chief medical officer of MindMed, a biopharmaceutical company in New York.
The study was published in the Journal of the American Medical Association.
THE KEY TO LIVING LONGER COULD BE TIED TO A SURPRISING SUBSTANCE, STUDY SUGGESTS
Nearly 200 adults between the ages of 18 and 74 received either a single oral dose of LSD at various does, or a placebo “dummy pill,” for a three-month period, according to a press release.
The dosing sessions were individually conducted in private rooms with two trained monitors who observed the participants for at least 12 hours. No psychotherapy was provided.
A new study suggests that lysergic acid diethylamide (LSD), also known as acid, could reduce anxiety. (iStock)
Researchers tracked changes in participants’ anxiety scores at weeks 1, 2, 4, 8 and 12, with week 4 serving as the main point of evaluation.
After the four weeks, patients receiving the highest doses had significantly lower anxiety scores than the others.
At 12 weeks, 65% of patients taking 100 milligrams showed benefits, with nearly 50% in remission from anxiety.
PSYCHEDELICS AS POTENTIAL MENTAL HEALTH TREATMENT ARE EXPLORED BY TRUMP ADMINISTRATION
Researchers also tested LSD’s impact on depression, finding that the highest doses were linked to significant improvements.
Karlin shared that the effects of LSD were almost immediate. Side effects of the psychedelic included hallucinations, nausea and headaches.
LSD was shown to reduce symptoms in adults with generalized anxiety disorder, with 100-microgram doses proving most effective in a clinical trial. (iStock)
The effects were dose-dependent, with 100 milligrams being the optimal dose. The 200-milligram dose also significantly outperformed the placebo. The 25-milligram and 50-milligram doses did not show significant benefits.
One possible study complication was “functional unbinding,” in which trial participants could correctly guess whether they had received the active medication versus a placebo, according to Karlin.
SINGLE DOSE OF ‘MAGIC MUSHROOMS’ PROVIDES 5 YEARS OF DEPRESSION RELIEF, RESEARCHERS FIND
The drugmaker plans to conduct two large, late-stage trials to track patients over a longer period of time.
If the study is deemed successful, MindMed will submit the drug to the U.S. Food and Drug Administration for approval.
Risks and legalities
LSD is classified as a Schedule I drug, which means it’s considered to have high potential for abuse and no accepted medical use, according to the Drug Enforcement Agency.
Schedule I drugs are not legally allowed to be prescribed, dispensed or used in medical treatment, except for approved research.
If the study is deemed successful, Mindmed will submit the experimental drug to the FDA for approval. (iStock)
The FDA has designated LSD, psilocybin and MDMA as “potential breakthrough therapies,” Fox News senior medical analyst Dr. Marc Siegel told Fox News Digital.
MILEY CYRUS REVEALS THE ‘POWERFUL’ THERAPY THAT HELPED HER CONQUER STAGE FRIGHT
“The key is careful oversight and meticulous research, which monitors both side effects and effectiveness,” said Siegel.
While this new study shows a “very positive result in around 200 patients,” Siegel confirmed that LSD can cause hallucinations.
Additional documented side effects may include paranoia, mood swings, increased heart rate and long-term psychosis, according to multiple sources.
“The key is careful oversight and meticulous research, which monitors both side effects and effectiveness.”
Hadas Alterman, a psychedelic medicine attorney in Washington, D.C., told Fox News Digital that “LSD’s return is not just cultural or scientific, it’s regulatory.”
The expert says psychedelics were “sidelined” due to the “sweeping expansion of FDA authority under the 1962 Kefauver–Harris Amendments.”
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
This legislation, also called the Drug Efficacy Amendments, required drug manufacturers to provide substantial evidence of efficacy through well-controlled clinical trials before approval.
“LSD and other psychedelics have long shown clinical promise, but the excess recreational use in the 1960s pushed researchers away from continuing to study it,” Siegel added.
“LSD and other psychedelics have long shown clinical promise, but the excess recreational use in the 1960s pushed researchers away from continuing to study it,” a doctor said. (iStock)
Health and Human Services Secretary Robert F. Kennedy Jr. and Department of Veterans Affairs Secretary Doug Collins have conveyed interest in exploring psychedelic therapy.
For more Health articles, visit www.foxnews.com/health
“This line of therapeutics has tremendous advantage if given in a clinical setting, and we are working very hard to make sure that happens within 12 months,” RFK recently told members of Congress, per AP.
Psychedelics advocate Alterman noted that while the support “doesn’t replace science,” it encourages institutions like FDA to “take this seriously.”
Health
‘Weight Loss Has Never Been About Calories’: How This Low-Insulin Diet Helped Lillie, 58, Drop 70 Lbs!
Use left and right arrow keys to navigate between menu items.
Use escape to exit the menu.
Sign Up
Create a free account to access exclusive content, play games, solve puzzles, test your pop-culture knowledge and receive special offers.
Already have an account? Login
Health
Weight-loss experts predict 5 major treatment changes likely to emerge in 2026
NEWYou can now listen to Fox News articles!
Big moves are continuing in the weight loss landscape in the new year following breakthrough research of GLP-1 medications and other methods.
Weight-loss experts spoke with Fox News Digital about their predictions for the most major changes to come in 2026.
No. 1: Shift to whole-body treatment
Dr. Peter Balazs, a hormone and weight loss specialist in New York and New Jersey, shared that the most important shift is likely to label GLP-1 drugs as “multi-system metabolic modulators” rather than “simple weight loss drugs.”
MORE AMERICANS MAY BE CLASSIFIED AS OBESE UNDER NEW DEFINITION, STUDY SUGGESTS
“The treatment goal is no longer just BMI reduction, but total cardiometabolic risk mitigation, with effects now documented across the liver, heart, kidneys and vasculature,” he said.
“We are seeing a significant reduction in major adverse cardiovascular events … and progression of renal disease,” he went on.
The focus of GLP-1 drugs will widen beyond weight loss and diabetes, according to experts’ predictions. (iStock)
Philip Rabito, M.D., a specialist in endocrinology, weight loss and wellness in New York City, also shared that “exciting” advancements lie ahead for weight-loss drugs, including GLP-1s and GIPs.
OLDER AMERICANS ARE QUITTING GLP-1 WEIGHT-LOSS DRUGS FOR 4 KEY REASONS
“These next‑generation agents, along with novel combinations that include glucagon and amylin agonists, are demonstrating even more impressive weight‑loss outcomes than currently available therapies, with the potential for better tolerability and sustained results,” he told Fox News Digital.
“There is also tremendous optimism around new federal agreements with manufacturers that aim to make these medications more widely accessible and affordable for the broad population of patients who need them most.”
No. 2: More convenient dosing
The typical prescription for a GLP-1 medication is a weekly injection, but delivery and dosing may be changing to more convenient methods in 2026, according to Balazs.
OPRAH JOINS WAVE OF CELEBRITIES WHO REVEALED DRAMATIC WEIGHT LOSS IN 2025
A daily 25 mg pill version of Novo Nordisk’s Wegovy, a semaglutide designed to treat obesity, is now approved and available for chronic weight management, offering a non-injectable option for some patients.
A once-weekly oral GLP-1 is currently in phase 2 trials, as well as an implant that aims for three to six months of drug delivery, Balazs noted.
Incisionless weight-loss procedures will rise as a lower-risk option, according to experts. (iStock)
No. 3: Less invasive surgery
In addition to decreased risk during surgery for GLP-1 users, Balazs also predicted that metabolic surgery without incision will rise as a better option.
“Incisionless endoscopic procedures — like endoscopic sleeve gastroplasty (non-surgical weight-loss procedure that makes the stomach smaller from the inside) and duodenal mucosal resurfacing (non-surgical procedure that resets part of the small intestine to help the body better handle blood sugar) — [may become] more durable and widely available,” he said.
TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ
“These offer significant metabolic benefits with shorter recovery and lower risk than traditional surgery.”
Rabito agreed that “rapid progress” in minimally invasive weight‑loss procedures is “opening powerful new options for patients who are hesitant to pursue traditional bariatric surgery.”
Bariatric surgery remains the most effective weight loss method, one specialist says. (iStock)
This avenue offers “meaningful and durable weight reduction with less risk, shorter recovery times and no external incisions,” the expert added.
Dr. Muhammad Ghanem, bariatric surgeon at the Orlando Health Weight Loss & Bariatric Surgery Institute, reiterated that surgery remains “the most successful modality for the treatment of obesity … with the highest weight loss and most durable outcomes as of yet.”
No. 4: Younger GLP-1 users
As Novo Nordisk’s Wegovy has been indicated for adolescents over 12 years old as an obesity treatment, Balazs commented that pediatric use of weight-loss drugs is “now a clinical reality.”
He predicted that other alternatives are likely to be approved in 2026 for younger users.
No. 5: High-tech, personalized access
Amid the growth of artificial intelligence, Balazs predicted an expansion in the clinical implementation of AI-driven weight-loss methods.
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
This could include categorizing obesity into sub-types like “hungry brain,” “emotional hunger” and “slow burn” to personalize how therapy is prescribed while moving away from “trial and error,” he said.
Ghanem agreed that there will likely be a “big focus” on individualized testing for causes of obesity in 2026, as it’s a disease that can have “different causes in different people,” thus requiring different treatments.
AI and other digital opportunities will drive more access for weight-loss patients, experts say. (iStock)
The doctor anticipates that more patients will seek combinations of comprehensive treatments and programs.
“Patients are more aware that now we have a few weapons in our arsenal to combat obesity, and [they] are seeking a multidisciplinary and holistic approach,” Ghanem said.
CLICK HERE FOR MORE HEALTH STORIES
Treatment options will also turn digital with the rise of prescription digital therapeutics (PDTs) for weight loss, Balazs predicted.
“These are software applications delivering cognitive behavioral therapy, personalized nutrition and metabolic coaching through algorithms, often integrated with continuous glucose monitors, and reimbursed as medical treatments,” he said.
CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER
Ghanem added that body composition analyzers, like DEXA scans, will likely be more widely used as awareness grows about the limitations of BMI and weight in assessing obesity.
Health
Brain Health Challenge: Doctor Appointments for Your Mind and Body
Congratulations, you’ve reached the final day of the Brain Health Challenge! Today, we’re asking you to do a few things that might feel a bit out of left field — like getting your blood pressure checked.
No, it isn’t as fun as playing Pips, but experts say it’s one of the most important things you can do for your brain. That’s because heart health and brain health are intrinsically linked.
High blood pressure, in particular, can damage brain cells, and it’s a significant risk factor for stroke and dementia. When blood pressure is too high, it places stress on the walls of arteries in the brain. Over time, that added stress can cause the blood vessel walls to thicken, obstructing blood flow. In other cases, the increased pressure causes the artery walls to thin and leak blood into the brain.
These changes to the blood vessels can sometimes cause a large stroke to occur. More commonly, the damage leads to micro-strokes and micro-hemorrhages, which cause fewer immediate problems and often go unnoticed. But if someone has hypertension for years or decades, these injuries can build up, and the person may start to experience cognitive impairment.
High blood pressure “is known as a silent killer for lots of reasons,” said Dr. Shyam Prabhakaran, the chair of neurology at the University of Chicago. “It doesn’t cause you any symptoms until it does.”
Because the damage accumulates over many years, experts say that managing blood pressure in midlife matters most for brain health. Hypertension can be addressed with medication or lifestyle changes, as directed by your doctor. But the first thing you need to do is know your numbers. If your blood pressure comes back higher than 120/80, it’s important to take it seriously, Dr. Prabhakaran said.
While you’re at it, there are a few other aspects of your physical health that you should check on.
Your eyes and ears are two of them. Hearing and vision loss have both been shown to increase the risk of dementia. Experts think that with less sensory information coming in to stimulate the brain, the regions that process hearing and vision can start to atrophy. What’s more, people with sensory loss often withdraw or are left out of social interactions, further depriving them of cognitive stimulation.
Oral health can also affect your brain health. Research has found a connection between regular flossing and reduced odds of having a stroke. That may be because good oral health can help to reduce inflammation in the body. The bacteria that cause gum disease have also been tied to an increased risk of Alzheimer’s.
And have you gotten your shingles vaccine? There is mounting evidence that it’s a powerful weapon for protecting against dementia. One study found that it lowered people’s odds of developing the condition by as much as 20 percent.
To wrap up this challenge, we want you to schedule a few medical appointments that benefit your brain, as well as your body.
After five days of feeding, exercising and challenging your brain, you are well on your way to better cognitive health. Thanks for joining me this week, and keep up the good habits!
-
Detroit, MI6 days ago2 hospitalized after shooting on Lodge Freeway in Detroit
-
Technology3 days agoPower bank feature creep is out of control
-
Dallas, TX5 days agoDefensive coordinator candidates who could improve Cowboys’ brutal secondary in 2026
-
Health5 days agoViral New Year reset routine is helping people adopt healthier habits
-
Iowa3 days agoPat McAfee praises Audi Crooks, plays hype song for Iowa State star
-
Nebraska3 days agoOregon State LB transfer Dexter Foster commits to Nebraska
-
Nebraska3 days agoNebraska-based pizza chain Godfather’s Pizza is set to open a new location in Queen Creek
-
Missouri3 days agoDamon Wilson II, Missouri DE in legal dispute with Georgia, to re-enter transfer portal: Source